|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4B
|
|
pubmed:dateCreated |
2008-8-28
|
|
pubmed:abstractText |
The optimum regimen and optimum duration of administration of postoperative chemotherapy would vary with the postoperative residual tumor volume. Whether or not prolonged administration of oral uracil/tegafur (UFT) with leucovorin (LV) would prolong the survival period was assessed experimentally.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0250-7005
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
28
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2045-8
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:18751373-Animals,
pubmed-meshheading:18751373-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:18751373-Chemotherapy, Adjuvant,
pubmed-meshheading:18751373-Colonic Neoplasms,
pubmed-meshheading:18751373-Disease Models, Animal,
pubmed-meshheading:18751373-Leucovorin,
pubmed-meshheading:18751373-Lung Neoplasms,
pubmed-meshheading:18751373-Male,
pubmed-meshheading:18751373-Mice,
pubmed-meshheading:18751373-Neoplasm Transplantation,
pubmed-meshheading:18751373-Tegafur,
pubmed-meshheading:18751373-Uracil
|
|
pubmed:articleTitle |
Long-term postoperative adjuvant chemotherapy of UFT/LV improves survival in a primary tumor resection-pulmonary metastasis model.
|
|
pubmed:affiliation |
Department of Surgery, Tokai University, Japan. sadahiro@is.icc.utokai.ac.jp
|
|
pubmed:publicationType |
Journal Article
|
